The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Patients' experiences of medication for anxiety and depression: effects on working life
Abstract
BACKGROUND: and objectives. The prevalence of depression and anxiety has increased in recent years, leading to extensive use of medication. This study used a qualitative, in-depth approach to investigate patients' experiences of taking medication prescribed for these conditions. Sampling from a range of occupational sectors, the research explored the impact of medication on working life. METHODS: The research involved nine focus groups with sufferers of anxiety and depression to investigate the personal experiences of mental ill-health and the impact of psychotropic drugs. A further three focus groups were conducted with staff in human resources, personnel, occupational health, and health and safety departments, to explore the organizational perspectives on psychotropic medication in the workplace. Focus groups were held at Loughborough University and at workplace settings throughout the UK. Results were presented to an expert panel (comprising practitioners and researchers in health care and occupational health) to consider implications for practice. RESULTS: Physical symptoms associated with anxiety and depression included: nausea, headaches, dizziness, trembling, insomnia and lack of energy. Psychological symptoms involved: poor concentration, emotional distress and lack of motivation. Non-compliance was widespread due to side effects, lack of improvement in symptoms or because medication made patients feel worse. Patients did not feel well informed about their medication. People took less than the prescribed amount or stopped taking the medication. Concerns about dependency caused patients to cease medication prematurely. CONCLUSION: Patients felt ill informed about their medication and would have welcomed more information. Drawing on the results, the authors outline areas for improvement in the care of patients with anxiety and depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Successful Focus Groups: Advancing the State of the Art
Morgan, D. (1993) · Sage eBooks · doi:10.4135/9781483349008 · Cited by 1,576
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
Mace, S., & Taylor, D. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315
Antidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214
Secular trends in antidepressant prescribing in the UK, 1975-1998
Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.262 · Cited by 168
Lawrenson, R., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00147-0 · Cited by 165
Antidepressant discontinuation syndromes
Haddad, P. M., Anderson, I., & Rosenbaum, J. (2004) · Adverse Syndromes and Psychiatric Drugs · doi:10.1093/med/9780198527480.003.0010 · Cited by 160
CRF/NPY interactions: A potential role in sleep dysregulation in depression and anxiety
Ehlers, C. L., Somes, C., Seifritz, E., & Rivier, J. E. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:1<40::aid-da6>3.0.co;2-9 · Cited by 91
Selective serotonin reuptake inhibitor discontinuation syndrome: A review
Tamam, L., & Özpoyraz, N. (2002) · Advances in Therapy · doi:10.1007/bf02850015 · Cited by 68
Enhancing patient outcomes: treatment adherence.
Frank, E. (1997) · PubMed · Cited by 57
Fortnightly Review: Treatment of anxiety
LADER, M. H. (1994) · BMJ · doi:10.1136/bmj.309.6950.321 · Cited by 54
Cited by
Patient Barriers to and Enablers of Deprescribing: a Systematic Review
Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0106-8 · Cited by 536
“A majority of the included studies had participants who expressed non-specific fears, such as ‘concerned about negative consequences of stopping’ [34], ‘stopping being seen as problematic’ [33] and ‘not sure that they would cope’ [40].”
BackgroundInfluentialMalpass, A., Shaw, A., Sharp, D., Walter, F., Feder, G., Ridd, M., & Kessler, D. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.09.068 · Cited by 368
Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
Prins, M. A., Verhaak, P. F. M., Bensing, J. M., & van der Meer, K. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.02.009 · Cited by 271
Mohammed, M. A., Moles, R. J., & Chen, T. F. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010035 · Cited by 250
Metadata
- Authors
- Haslam, C.
- Venue
- Family Practice
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-01
- Volume
- 21
- Issue
- 2
- Pages
- 204-212
- ISSN
- 0263-2136 (ISSN-L)
- 1460-2229
- OpenAlex
- W2166639431
- Cited by
- 63
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Family Practice (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Workplace Health and Well-being
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- anxiety, depression, psychotropic drugs, patient experience, adverse drug reactions, medication non-adherence, occupational health, workplace mental health, working life, patient information, human resources department
- MeSH terms
- Adolescent, Adult, Anxiety Disorders, Attention, Depression, Employment, Family Practice, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Occupational Health Services, Patient Education as Topic, Psychology, Industrial, Psychotropic Drugs, Quality of Life, Work, Treatment Refusal, Patient Satisfaction, Focus Groups, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patients' experiences of medication for anxiety and depression: effects on working life. https://app.cochat.ai/papers/10.1093/fampra/cmh218
- The paper
- Haslam, C. (2004). Patients' experiences of medication for anxiety and depression: effects on working life. Family Practice. https://doi.org/10.1093/fampra/cmh218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.